FHLCvsXLVETF Comparison
VS
Fidelity MSCI Health Care Index ETF (FHLC) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. FHLC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, XLV's top sector exposures are Healthcare, Consumer Non-Cyclicals FHLC is more expensive with a Total Expense Ratio (TER) of 0.084%, versus 0.08% for XLV. FHLC is up 6.92% year-to-date (YTD) with +$252M in YTD flows. XLV performs worse with 6.46% YTD performance, and +$350M in YTD flows. Run a side-by-side ETF comparison of FHLC and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FHLC vs XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FHLC XLV | +5.75%+1.61% | +13.55%+14.41% | +6.92%+6.46% | +24.23%+22.86% | +27.84%+27.46% | +29.62%+35.04% |
| Flows | FHLC XLV | +$28M+$377M | +$77M-$876M | +$252M+$350M | +$283M+$1.43B | -$444M-$5.35B | -$73M+$2.67B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FHLC XLV | +17.45%+18.21% | +15.28%+15.70% | +14.36%+14.33% | +15.25%+14.97% |
| Max drawdown | FHLC XLV | -3.84%-3.83% | -10.35%-10.51% | -16.88%-17.05% | -17.78%-17.05% |
| Max drawdown duration | FHLC XLV | 17d20d | 169d116d | 435d444d | 762d444d |
Trading data
FHLC | XLV | |
Last sale 7/28/2026 at 5:10 PM | $80.84 | $167.11 |
| Previous close 07/27/2026 | $79.26 | $163.40 |
| Consolidated volume 07/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FHLC | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/28/2026 at 5:10 PM
Live
Closed
FHLC | XLV | |
|---|---|---|
| Last price | $80.84 | $167.11 |
| 1D performance | +1.99% | +2.27% |
| AuM | $3.29 B | $42.15 B |
| E/R | 0.084% | 0.08% |
Characteristics
FHLC | XLV | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Fidelity | State Street Investment Management |
| Benchmark | MSCI USA IMI Health Care 25/50 Index | S&P Health Care Select Sector Index |
| N° of holdings | 333 | 59 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 21, 2013 | December 16, 1998 |
| ESG | No | No |
Advertisement
Exposure
Countries
FHLC
USA
96.98%
Other
3.02%
XLV
USA
97.92%
Other
2.08%
Sectors
FHLC
Healthcare
97.66%
Other
2.34%
XLV
Healthcare
97.73%
Other
2.27%
Advertisement
Diversification
FHLC
Total weight of top 15 holdings out of 15
61.21%
XLV
Total weight of top 15 holdings out of 15
72.82%
Top 15 holdings
Data as of June 30, 2026
FHLC
Eli Lilly & Co.
13.60%
Johnson & Johnson
8.86%
AbbVie, Inc.
6.46%
UnitedHealth Group, Inc.
5.67%
Merck & Co., Inc.
4.66%
Amgen, Inc.
2.86%
Thermo Fisher Scientific, Inc.
2.82%
Abbott Laboratories
2.44%
Gilead Sciences, Inc.
2.31%
Intuitive Surgical, Inc.
2.13%
Pfizer Inc.
2.02%
CVS Health Corp.
2.00%
Danaher Corp.
1.84%
Vertex Pharmaceuticals, Inc.
1.83%
Bristol Myers Squibb Co.
1.70%
XLV
Eli Lilly & Co.
16.57%
Johnson & Johnson
10.68%
AbbVie, Inc.
7.76%
UnitedHealth Group, Inc.
6.59%
Merck & Co., Inc.
5.54%
Amgen, Inc.
3.41%
Thermo Fisher Scientific, Inc.
3.25%
Abbott Laboratories
2.76%
Gilead Sciences, Inc.
2.74%
Intuitive Surgical, Inc.
2.46%
Pfizer Inc.
2.40%
CVS Health Corp.
2.31%
Vertex Pharmaceuticals, Inc.
2.20%
Danaher Corp.
2.10%
Bristol Myers Squibb Co.
2.05%
Frequently asked questions about FHLC and XLV
How have the FHLC and XLV ETFs performed in 2026?
As of July 24, 2026, FHLC is up 6.92% year-to-date (YTD), while XLV has returned 6.46%. That puts FHLC better performer ahead so far this year.
Which ETF is attracting more investor money: FHLC or XLV?
Year-to-date, the FHLC ETF saw +$252M in flows, compared to +$350M for XLV.
Which ETF is more volatile: FHLC or XLV?
Over the past year, FHLC had a volatility of 15.28%, while XLV experienced 15.7%.
Which ETF is bigger: FHLC or XLV?
As of July 24, 2026, FHLC holds $3.29 B in assets under management (AUM), while XLV manages $42.15 B.
What sectors do the FHLC and XLV ETFs invest in?
FHLC leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.
What are the top holdings of the FHLC ETF and XLV ETF?
FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: FHLC or XLV?
FHLC holds 337 securities with 61.21% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 72.82%.
Advertisement
Latest news about FHLC & XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
